AmbioPharm is excited to announce our participation in the Boulder Peptide Symposium 2025. As a leading peptide-focused CDMO, we look forward to connecting with researchers, biotech and pharma companies to discuss how our expertise can accelerate peptide therapeutics from discovery through commercialization.
Visit us at booth #2. Contact us to schedule an appointment during the event.
中文